Erik Berntorp

Senior Professor
More filtering options
  1. 2021
  2. Bleeding phenotype of patients with moderate haemophilia A and B assessed by thromboelastometry and thrombin generation

    Ragnhild J. Måseide, Erik Berntorp, Vuokko Nummi, Riitta Lassila, Geir E. Tjønnfjord & Pål A. Holme, 2021, In: Haemophilia.

    Research output: Contribution to journalArticle

  3. Haemophilia early arthropathy detection with ultrasound and haemophilia joint health score in the moderate haemophilia (MoHem) study

    Ragnhild J. Måseide, Erik Berntorp, Jan Astermark, Jessica Hansen, Anna Olsson, Maria Bruzelius, Tony Frisk, Magnus Aspdahl, Vuokko Nummi, Geir E. Tjønnfjord & P. Holme, 2021, In: Haemophilia. 27, 2

    Research output: Contribution to journalArticle

  4. The B-Natural study—The outcome of immune tolerance induction therapy in patients with severe haemophilia B

    Jan Astermark, Katharina Holstein, Yasmina L. Abajas, Susan Kearney, Stacy E. Croteau, Riana Liesner, Eva Funding, Christine L. Kempton, Suchitra Acharya, Stefan Lethagen, Petra LeBeau, Joel Bowen, Erik Berntorp & Amy D. Shapiro, 2021, In: Haemophilia.

    Research output: Contribution to journalArticle

  5. Translating the success of prophylaxis in haemophilia to von Willebrand disease

    Wolfgang Miesbach & Erik Berntorp, 2021, In: Thrombosis Research. 199, p. 67-74 8 p.

    Research output: Contribution to journalReview article

  6. Treatment outcomes in persons with severe haemophilia B in the Nordic region: The B-NORD study

    Kristina Kihlberg, Fariba Baghaei, Maria Bruzelius, Eva Funding, Pål Andre Holme, Riitta Lassila, Vuokko Nummi, Susanna Ranta, Mehdi Osooli, Erik Berntorp & Jan Astermark, 2021, In: Haemophilia.

    Research output: Contribution to journalArticle

  7. 2020
  8. Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A

    Alexander Solms, Anita Shah, Erik Berntorp, Andreas Tiede, Alfonso Iorio, Camila Linardi, Maurice Ahsman, Maria Elisa Mancuso, Tihomir Zhivkov & Toshko Lissitchkov, 2020 Nov 1, In: Annals of Hematology. 99, 11, p. 2689-2698 10 p.

    Research output: Contribution to journalArticle

  9. Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS-IPS, an international and collaborative cross-sectional study

    Alberto Tosetto, Zahra Badiee, Mohammad Reza Baghaipour, Luciano Baronciani, Javier Battle, Erik Berntorp, Imre Bodó, Ulrich Budde, Giancarlo Castaman, Jeroen C.J. Eikenboom, Peyman Eshghi, Cosimo Ettorre, Anne Goodeve, Jenny Goudemand, Charles Richard Morris Hay, Hamid Hoorfar, Mehran Karimi, Bijan Keikhaei, Riitta Lassila, Frank W.G. Leebeek & 15 others, Maria Fernanda Lopez Fernandez, Pier Mannuccio Mannucci, Maria Gabriella Mazzucconi, Massimo Morfini, Johannes Oldenburg, Ian Peake, Rafael Parra Lòpez, Flora Peyvandi, Reinhard Schneppenheim, Andreas Tiede, Gholamreza Toogeh, Marc Trossaert, Omidreza Zekavat, Eva M.K. Zetterberg & Augusto B. Federici, 2020 Sep 1, In: Journal of Thrombosis and Haemostasis. 18, 9, p. 2145-2154 10 p.

    Research output: Contribution to journalArticle

  10. Joint health and treatment modalities in Nordic patients with moderate haemophilia A and B – The MoHem study

    Ragnhild J. Måseide, Erik Berntorp, Jan Astermark, Anna Olsson, Maria Bruzelius, Tony Frisk, Vuokko Nummi, Riitta Lassila, Geir E. Tjønnfjord & Pål A. Holme, 2020 Sep, In: Haemophilia. 26, 5, p. 891-897 7 p.

    Research output: Contribution to journalArticle

  11. Modeling to Predict Factor VIII Levels Associated with Zero Bleeds in Patients with Severe Hemophilia A Initiated on Tertiary Prophylaxis

    Pratima Chowdary, Kathelijn Fischer, Peter W. Collins, Amy Cotterill, Barbara A. Konkle, Victor Blanchette, Steven W. Pipe, Erik Berntorp, Martin Wolfsegger, Werner Engl & Gerald Spotts, 2020 May 5, In: Thrombosis and Haemostasis. 120, 5, p. 728-736 9 p.

    Research output: Contribution to journalArticle

  12. Favorable Pharmacokinetic Characteristics of Extended-Half-Life Recombinant Factor VIII BAY 94-9027 Enable Robust Individual Profiling Using a Population Pharmacokinetic Approach

    Alexander Solms, Alfonso Iorio, Maurice J. Ahsman, Peter Vis, Anita Shah, Erik Berntorp & Dirk Garmann, 2020 May, In: Clinical Pharmacokinetics. 59, 5, p. 605-616 12 p.

    Research output: Contribution to journalArticle

  13. Achieving the unimaginable: Health equity in haemophilia

    Mark W. Skinner, Diane Nugent, Pam Wilton, Brian O’Mahony, Gerry Dolan, Jamie O’Hara & Erik Berntorp, 2020 Jan, In: Haemophilia. 26, 1, p. 17-24 8 p.

    Research output: Contribution to journalReview article

  14. 2019
  15. ROTEM and vitro reversal of warfarin with APCC

    Ludvig Kornhall, Daniel Wikander, Karin Strandberg, Erik Berntorp & Ulf Schott, 2019 Mar 18, In: Journal of Cardiovascular Medicine and Cardiology. 6, 1, p. 6-11

    Research output: Contribution to journalArticle

  16. A personalized approach to the management of VWD

    Chai W. Phua & Erik Berntorp, 2019, In: Transfusion and Apheresis Science. 58, 5, p. 590-595

    Research output: Contribution to journalArticle

  17. Coagulation factor VIII is vital for increasing global coagulation after physical exercise

    Marcus Ljungkvist, Henric Olofsson, Eva Funding, Erik Berntorp & Eva Zetterberg, 2019, In: Haemophilia. 25, 2, p. e86-e93

    Research output: Contribution to journalArticle

  18. Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A

    Anita Shah, Alexander Solms, Sara Wiegmann, Maurice Ahsman, Erik Berntorp, Andreas Tiede, Alfonso Iorio, Maria Elisa Mancuso, Tihomir Zhivkov & Toshko Lissitchkov, 2019, In: Annals of Hematology. 98, 9, p. 2035-2044

    Research output: Contribution to journalArticle

  19. Evaluation of a standardized protocol for thrombin generation using the calibrated automated thrombogram: A Nordic study

    Marcus Ljungkvist, Karin Strandberg, Erik Berntorp, Roza Chaireti, Pål André Holme, Ole Halfdan Larsen, Riitta Lassila, Annukka Jouppila, Timea Szanto & Eva Zetterberg, 2019, In: Haemophilia. 25, 2, p. 334-342

    Research output: Contribution to journalArticle

  20. Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factor

    Flora Peyvandi, Peter Kouides, Peter L. Turecek, Edward Dow & Erik Berntorp, 2019, In: Blood Reviews. 38, 100572.

    Research output: Contribution to journalReview article

  21. Factor VIII: Long-established role in haemophilia A and emerging evidence beyond haemostasis

    Bethany Samuelson Bannow, Michael Recht, Claude Négrier, Cédric Hermans, Erik Berntorp, Hermann Eichler, Maria Elisa Mancuso, Robert Klamroth, Jamie O'Hara, Elena Santagostino, Tadashi Matsushita & Craig Kessler, 2019, In: Blood Reviews. 35, p. 43-50

    Research output: Contribution to journalReview article

  22. Hypertension and cardiovascular diseases in Swedish persons with haemophilia — A longitudinal registry study

    Susanna Lövdahl, Karin M. Henriksson, Fariba Baghaei, Margareta Holmström, Erik Berntorp & Jan Astermark, 2019, In: Thrombosis Research. 181, Sept., p. 106-111

    Research output: Contribution to journalArticle

  23. Joint comorbidities among Swedish carriers of haemophilia: A register-based cohort study over 22 years

    Mehdi Osooli, Sharyne M. Donfield, Katarina Steen Carlsson, Fariba Baghaei, Margareta Holmström, Erik Berntorp & Jan Astermark, 2019, In: Haemophilia. 25, 5, p. 845-850

    Research output: Contribution to journalArticle

  24. Moderate haemophilia in focus

    Erik Berntorp, 2019, In: Haemophilia. 25, 2, p. 187-188

    Research output: Contribution to journalDebate/Note/Editorial

  25. Sports participation and physical activity in adult Dutch and Swedish patients with severe haemophilia: A comparison between intermediate- and high-dose prophylaxis

    Olav Versloot, Erik Berntorp, Pia Petrini, Rolf Ljung, Jan Astermark, Margareta Holmström, Piet de Kleijn & Kathelijn Fischer, 2019, In: Haemophilia. 25, 2, p. 244-251

    Research output: Contribution to journalArticle

  26. 2018
  27. Fifth Åland Island conference on von Willebrand disease

    E. Berntorp, A. Ågren, L. Aledort, M. Blombäck, M. H. Cnossen, S. E. Croteau, M. von Depka, A. B. Federici, A. Goodeve, J. Goudemand, P. M. Mannucci, M. Mourik, P. T. Önundarson, F. Rodeghiero, T. Szántó & J. Windyga, 2018 May 1, In: Haemophilia. 24, p. 5-19 15 p.

    Research output: Contribution to journalArticle

  28. Replacement therapy during surgery in von Willebrand disease needs personalization

    E. Berntorp, 2018 May 1, In: Haemophilia. 24, 3, p. 338-340 3 p.

    Research output: Contribution to journalDebate/Note/Editorial

  29. Defining extended half-life rFVIII-A critical review of the evidence

    J. Mahlangu, G. Young, C. Hermans, V. Blanchette, E. Berntorp & E. Santagostino, 2018 May, In: Haemophilia. 24, 3, p. 348-358

    Research output: Contribution to journalArticle

  30. Pharmacokinetic modelling and validation of the half-life extension needed to reduce the burden of infusions compared with standard factor VIII

    C. Hermans, J. Mahlangu, J. Booth, H. Schütz, E. Santagostino, G. Young, H. Y. Lee, K. N. Steinitz-Trost, V. Blanchette & E. Berntorp, 2018 May, In: Haemophilia. 24, 3, p. 376-384

    Research output: Contribution to journalArticle

  31. Immune tolerance induction: What have we learned over time?

    H. H. Brackmann, G. C. White, E. Berntorp, T. Andersen & C. Escuriola-Ettingshausen, 2018 Apr 1, In: Haemophilia. 24, p. 3-14 12 p.

    Research output: Contribution to journalReview article

  32. Evaluation of prophylactic therapy in haemophilia with global coagulation tests

    E. Zetterberg, K. Brolin, R. Lindahl, K. Knobe & E. Berntorp, 2018 Jan 1, In: Haemophilia. 24, 1, p. e10-e13

    Research output: Contribution to journalLetter

  33. The elevated prevalence of risk factors for chronic liver disease among ageing people with hemophilia and implications for treatment

    Christian Qvigstad, Robert Campbell Tait, Stephan Rauchensteiner, Erik Berntorp, Philippe de Moerloose, Roger E. Schutgens, Pål Andre Holme & ADVANCE Working Group ADVANCE Working Group, 2018, In: Medicine. 97, 39, e12551.

    Research output: Contribution to journalArticle

  34. 2017
  35. Preference-based valuation of treatment attributes in haemophilia A using web survey

    K. Steen Carlsson, E. Andersson & E. Berntorp, 2017 Nov 1, In: Haemophilia. 23, 6, p. 894-903 10 p.

    Research output: Contribution to journalArticle

  36. Comparative burden of arthropathy in mild haemophilia: a register-based study in Sweden

    M Osooli, S Lövdahl, K Steen Carlsson, K Knobe, F. Baghaei, M Holmström, J Astermark & E Berntorp, 2017 Mar, In: Haemophilia. 23, 2, p. e79-e86

    Research output: Contribution to journalArticle

  37. The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany

    Erik Berntorp, Yesim Dargaud, Daniel P. Hart, Sébastien Lobet, Maria Elisa Mancuso, Roseline d'Oiron, David Perry, Debra Pollard, Marijke van den Berg, Jan Blatný, Hervé Chambost, Andrea S. Doria, Pål André Holme, Radoslaw Kaczmarek, Lorenzo Mantovani, Paul McLaughlin, Lochana Nanayakkara, Pia Petrini, Thomas Sannié, Edward Laane & 6 others, Raquel Maia, Athina Dettoraki, Anna Farrell, Susan Halimeh, Sayma Raza & Stephanie Taylor, 2017 Jan 1, In: European Journal of Haematology. 98, s85, p. 1-15 15 p.

    Research output: Contribution to journalArticle

  38. European retrospective study of real-life haemophilia treatment

    E. Berntorp, G. Dolan, C. Hay, S. Linari, E. Santagostino, A. Tosetto, G. Castaman, Mt Álvarez-Román, R. Parra Lopez, J. Oldenburg, T. Albert, U. Scholz, M. Holmström, J. F. Schved, M. Trossaërt, C. Hermans, A. Boban, C. Ludlam & S. Lethagen, 2017 Jan, In: Haemophilia. 23, 1, p. 105-114

    Research output: Contribution to journalArticle

  39. Anti-factor VIII antibodies in brothers with haemophilia A share similar characteristics

    J. Kahle, A. Orlowski, D. Stichel, J. F. Healey, E. T. Parker, S. M. Donfield, J. Astermark, E. Berntorp, P. Lollar, D. Schwabe & C. Königs, 2017, In: Haemophilia. 23, 2, p. 292-299

    Research output: Contribution to journalArticle

  40. Correlation to FVIII: C in two thrombin generation tests: TGA-CAT and INNOVANCE ETP

    Marcus Ljungkvist, Maria Berndtsson, Margareta Holmström, Danijela Mikovic, Ivo Elezovic, Jovan P. Antovic, Eva Zetterberg & Erik Berntorp, 2017, In: Mediterranean Journal of Hematology and Infectious Diseases. 9, 1, e2017064.

    Research output: Contribution to journalArticle

  41. Low agreement between fresh and frozen-thawed platelet-rich plasma in the calibrated automated thrombogram assay

    M. Ljungkvist, S. Lövdahl, E. Zetterberg & E. Berntorp, 2017, In: Haemophilia. 23, 3, p. e214-e218

    Research output: Contribution to journalArticle

  42. Plasma-derived versus recombinant factor concentrates in PUPs: A never ending debate?

    Erik Berntorp, 2017, In: Hämostaseologie. 37, 1, p. 53-57 5 p.

    Research output: Contribution to journalArticle

  43. The association between health utility and joint status among people with severe haemophilia A: findings from the KAPPA register

    M Osooli, K Steen Carlsson, F Baghaei, M Holmström, S. Rauchensteiner, P A Holme, L Hvitfeldt, J Astermark & E Berntorp, 2017, In: Haemophilia. 23, 3, p. e180-e187

    Research output: Contribution to journalArticle

  44. The importance of genetic factors for the development of arthropathy: A longitudinal study of children and adolescents with haemophilia A

    Edward D Gomperts, John Schwarz, Sharyne M. Donfield, Alice E. Lail, Jan Astermark, W. Keith Hoots, Cheryl A. Winkler & Erik Berntorp, 2017, In: Thrombosis and Haemostasis. 117, 2, p. 277-285 9 p.

    Research output: Contribution to journalArticle

  45. Thrombin generation assays (TGAs)

    Gian Luca Salvagno & Erik Berntorp, 2017, Methods in Molecular Biology. Humana Press, Vol. 1646. p. 515-522 8 p. (Methods in Molecular Biology; vol. 1646).

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  46. Von Willebrand disease - the 'Dos' and 'Don'ts' in surgery

    Wolfgang Miesbach & Erik Berntorp, 2017, In: European Journal of Haematology. 98, 2, p. 121-127

    Research output: Contribution to journalArticle

  47. 2016
  48. Malignancies in Swedish persons with haemophilia: a longitudinal registry study

    Susanna Lövdahl, K M Henriksson, Fariba Baghaei, Margareta Holmström, Erik Berntorp & Jan Astermark, 2016 Sep, In: Blood Coagulation and Fibrinolysis. 27, 6, p. 631–636

    Research output: Contribution to journalArticle

  49. Haemophilia treatment in 2030

    E. Berntorp, 2016 Jul 1, In: Haemophilia. 22, S5, p. 15-19 5 p.

    Research output: Contribution to journalArticle

  50. The first Team Haemophilia Education meeting, 2015, Amsterdam, The Netherlands

    Erik Berntorp, Daniel Hart, Maria Elisa Mancuso, Roseline d'Oiron, David Perry, Brian O'Mahony, Radoslaw Kaczmarek, Miguel Crato, John Pasi, Alec Miners, Katarina Steen Carlsson, Steve Kitchen, Françoise Boehlen, Paul Giangrande, Elizabete Cebura, Nanda Uitslager, Mehdi Osooli, Daniela Janeckova, Rosie Haldon & Gianna Franca Rivolta, 2016 Jul 1, In: European Journal of Haematology. 97, p. 3-18 16 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 4 5 6 7 Next